Overview

24-hour Effect of Rocklatan Compared With Latanoprost in Open Angle Glaucoma and Ocular Hypertension Patients

Status:
ACTIVE_NOT_RECRUITING

Trial end date:
2027-10-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to evaluate the effect on 24-hour IOP reduction of netarsudil-latanoprost fixed combination in one eye compared to latanoprost alone in the contralateral eye, dosed daily, 1 drop at night (QD, PM) in adult subjects, at least 18 years of age, with open angle glaucoma (OAG) or ocular hypertension (OHT).

Phase:

PHASE4

Details

Lead Sponsor:

Mayo Clinic

Collaborator:

Alcon Research

Treatments:

Latanoprost
netarsudil
Ophthalmic Solutions